mRNA

Traditional scale-down models lack true perfusion capabilities, therefore not optimum for the perfusion media development process. Mobius® Breez microbioreactors with true perfusion capability are highly predictable to larger scale bioreactors, thus significantly enhancing our current workflow.

Single-use technologies are well-suited for the manufacture of mRNA. Not only do they offer increased flexibility, they can…

Chemical Engineering Magazine has published its second article of the biopharmaceutical manufacturing series, written by Biomanufacturing Engineer, David…